Body composition to define prognosis of cancers treated by anti-angiogenic drugs

HIGHLIGHTS

• who: Pierre Decazes and colleagues from the Department of Medical Imaging and Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France QuantIF-LITIS (EA [Equipe d` Accueil], ), Faculty of Medicine, University of Rouen, Rouen, France have published the research work: Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs, in the Journal: Diagnostics 2023, 13, x FOR PEER REVIEW A of /2023/
• what: The aim of this study is to evaluate the prognostic value of 3D and 2D anthropometric parameters in patients given treatments. The authors investigated the contribution of body composition in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.